Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII). (Q39515308)
Jump to navigation
Jump to search
scientific article published on 4 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII). |
scientific article published on 4 August 2011 |
Statements
1 reference
Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII). (English)
1 reference
1 reference
Katja Klausz
1 reference
Sven Berger
1 reference
Jeroen J Lammerts van Bueren
1 reference
Stefanie Derer
1 reference
Stefan Lohse
1 reference
Michael Dechant
1 reference
Jan G J van de Winkel
1 reference
Matthias Peipp
1 reference
Thomas Valerius
1 reference
4 August 2011
1 reference
1 reference
102
1 reference
10
1 reference
1761-1768
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference